Market Pulse: Wall Street drifted to a mixed close as traders shrugged off year-end jitters and now eye a cautious open. Key Movers: “ETMarkets Smart Talk | Gold, Silver unlikely to repeat 2025 rally; geopolitics key in 2026:...
Category - Hot Stocks
MCO: Moody’s Insights on Orlando Airport Closure Impact
Introduction Moody’s Corporation (NYSE: MCO) – sharing a ticker symbol with the code for Orlando International Airport (MCO) – is one of the world’s dominant credit rating agencies and financial analytics firms. This report...
Markets on Edge as FIIs Pull ₹2 Lakh Crore
Morning Recap Equity flows lurched as foreign institutional investors yanked roughly Rs 2 lakh crore from six marquee sectors, dragging the benchmark into a tight trading band and leaving domestic buyers on edge. Banks, auto...
CHR: New therapy trial could reshape youth mental health!
([1]) ([2])Despite an eye-catching title suggesting a breakthrough in youth mental health, the ticker CHR actually represents Chorus Aviation Inc. – a Canadian aviation company. Chorus operates regional airline services...
Holiday Market Surge Fueled by AI Mega-Deals
Daily Financial Update Good morning. It’s Thursday, December 25, 2025—yes, markets are half-staffed, but surprisingly lively. Here’s the unvarnished scoop on what moved (and might move) your money today. Market Pulse: Tech M&A...
CNS: Cassava’s Settlement Sparks Investor Opportunity!
Company Overview and Recent Developments Cassava Sciences, Inc. (NASDAQ: SAVA) is a clinical-stage biotechnology company focused on central nervous system (CNS) disorders, including Alzheimer’s disease and a new program in...
Overweight India Financials Ahead of 2026 Market Shift
Opening Recap Market Pulse: Global markets drifted on mixed footing as retail investors capped another banner year, while strategists flagged “precarious” as 2026’s defining mood. Key Movers: India’s indices held near flat amid a...
SAVA: Settlement Agreement Could Ignite Stock Surge!
Company Overview Cassava Sciences, Inc. (NASDAQ: SAVA) is a clinical-stage biotechnology company based in Austin, Texas, focused on developing novel treatments for central nervous system disorders ([1]). The company’s primary...
Cement Consolidation, Fed Jitters, and Big Stock Plays
Market Pulse: Yesterday’s action revolved around strategic moves in cement, surprise share swings, and fresh Fed-watch tension. Markets drifted on merger and Fed jitters, leaving investors squinting at strategy over spectacle...
APLM Surges: First Half 2025 Financial Results Unveiled!
First Half 2025 Financial Highlights Improved earnings picture: Apollomics (NASDAQ: APLM) reported a significantly smaller net loss of $12.5 million for H1 2025, a sharp improvement from the $35.2 million loss in H1 2024 ([1])...